Rigel Pharmaceuticals reported $171.1M in Current Assets for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Acceleron Pharma XLRN:US $ 696.61M 21.16M
Acura Pharmaceuticals ACUR:US 1.31M 70K
Alexion Pharmaceuticals ALXN:US $ 6452.6M 619.6M
Amgen AMGN:US $ 24380M 5281M
Anika Therapeutics ANIK:US $ 165.78M 11.98M
Applied Genetic Technologies AGTC:US $ 93.39M 16.32M
Arrowhead Research ARWR:US $ 384.6M 141.36M
Astrazeneca AZN:US 26.69B 583M
AstraZeneca AZN:LN 26.69B 583M
Biomarin Pharmaceutical BMRN:US $ 2311.57M 46.27M
Bristol Myers Squibb BMY:US $ 31443M 2282M
Celldex Therapeutics CLDX:US $ 426.56M 258.95M
Chemocentryx CCXI:US $ 293.38M 23.75M
Daiichi Sankyo 4568:JP Y 1270181M 36484M
Dicerna Pharmaceuticals DRNA:US $ 589M 27.49M
Eli Lilly And LLY:US $ 17808.3M 512.8M
Flexion Therapeutics FLXN:US $ 192.76M 8.64M
Halozyme Therapeutics HALO:US $ 1017.3M 17.55M
Heron Therapeutics HRTX:US $ 315.05M 51.77M
Immunogen IMGN:US $ 296.8M 22.41M
Intrexon XON:US $ 153.09M 3.59M
IONIS PHARMACEUT IONS:US $ 2156M 82.42M
Karyopharm Therapeutics KPTI:US $ 241.58M 31.92M
Ligand Pharmaceuticals LGND:US $ 432.08M 21.18M
Macrogenics MGNX:US $ 334.7M 32.3M
Neurocrine Biosciences NBIX:US $ 1005.7M 104.4M
Regeneron Pharmaceuticals REGN:US $ 13775.4M 437.8M
Rigel Pharmaceuticals RIGL:US $ 171.1M 13.09M
Sangamo Biosciences SGMO:US $ 447.4M 106.67M
Ultragenyx Pharmaceutical RARE:US $ 846.88M 102.61M
Veracyte VCYT:US $ 229.31M 142.04M